德明利(001309.SZ):推出eMMC、UFS、LPDDR等產品,已完成主流客戶認證導入,實現批量出貨
格隆匯2月20日丨德明利(001309.SZ)在投資者關係表示,上市以來,公司持續在嵌入式存儲業務發力,持續推動包括團隊組建、產品研發、客戶拓展等工作。嵌入式存儲因在實際應用場景中產品生命週期較長、客戶替換成本高,導致下遊前期驗證要求嚴格、時間週期長。公司通過組建優秀嵌入式團隊,針對客戶定製化需求,提供全流程技術支持,推出了eMMC、UFS、LPDDR等產品,經過長期技術攻關,已完成主流客戶認證導入,實現批量出貨。公司未來將延續“技術-客戶”雙輪驅動,持續拓展嵌入式產品矩陣,將前期驗證壁壘轉化爲長期競爭壁壘,推動嵌入式存儲成爲業績新增長點。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.